A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of ...

Sanofi's antibody riliprubart has received orphan drug designation from Japan's MHLW for its potential to treat CIDP.

ADMA Biologics ADMA markets plasma-derived biologics for the treatment of immune deficiencies and prevention of certain ...

Gammagard Liquid ERC is a ready-to-use formulation with low IgA content designed to ease administration burden by removing the need to reconstitute.

The intravenous immunoglobulin (IVIG) market is experiencing significant growth due to the rising prevalence of autoimmune diseases, immune deficiencies, and neurological disorders.

It is the only ready-to-use liquid immunoglobulin therapy with (IgA) content and is set for commercialization in 2026.

Intravenous Immunoglobulin Likely More Effective Than Corticosteroids in Chronic Inflammatory Demyelinating Polyneuropathy. S. Andrew Josephson, MD. Disclosures. AccessMedicine from McGraw-Hill .

A first-of-its-kind clinical trial clinical trial shows that therapeutic plasma exchange (TPE) combined with intravenous immunoglobin reduced biological age on average by 2.6 years, as measured by ...

The intravenous immunoglobulin (IVIG) market is experiencing significant growth due to the rising prevalence of autoimmune diseases, immune deficiencies, and neurological disorders. Advancements ...